Open AccessPharmacoeconomic analysis of Giotrif® (afatinib) as first-line treatment of metastatic non-small cell lung cancer with Del19 mutation of epidermal growth factor receptor (EGFR) gene
Author(s) -
Vera Gorbunova,
С. В. Орлов,
С. К. Зырянов,
Дмитрий Юрьевич Белоусов
Publication year - 2015
Publication title -
zlokačestvennye opuholi
Language(s) - English
Resource type - Journals
eISSN - 2587-6813
pISSN - 2224-5057
DOI - 10.18027/2224-5057-2015-4-35-47
Subject(s) - afatinib , erlotinib , medicine , pemetrexed , gefitinib , oncology , lung cancer , epidermal growth factor receptor , cisplatin , chemotherapy , cancer